Short-term follow-up of patients with sickle cell disease and albuminuria

Ofelia A Alvarez, Gabriela Lopez-Mitnik, Gaston E Zilleruelo

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background. Albuminuria with normal serum creatinine occurs frequently in patients with sickle cell disease (SCD), but the rate of progression to more advanced chronic renal disease is unknown. The purpose of this study was to investigate the rate of progression of children and young adults with SCD and albuminuria over time. Procedure. Urine albumin/creatinine (A/C) ratios and serum creatinine were obtained serially. Serum cystatin C levels were determined in a subgroup of 20 patients. Results. Of 38 patients with SCD who had albuminuria (30 with microalbuminuria and 8 with proteinuria), 10.5% had progressive disease during follow-up of 20 ± 12 months. Progressive disease was observed in 2 of 30 patients with MA because MA worsened to either intermittent proteinuria (1 patient), or persistent proteinuria after 7 months follow-up (1 patient). Two of eight patients with proteinuria worsened to nephrotic-range after 8 and 17 months with elevations of serum creatinine. All eight patients with proteinuria were treated with angiotensin blockade and/or hydroxyurea. Of those, six patients responded to treatment with decreased albuminuria and no changes in serum creatinine. Serum cystatin C level trended to increase before serum creatinine in patients with proteinuria. Conclusions. Patients with rapid progression to nephrotic-range proteinuria showed decreased kidney function. Therefore, patients with albuminuria should be monitored closely for progression, and therapy with hydroxyurea and/or angiotensin blockade should be considered for patients who develop proteinuria. Serum cystatin C appears more sensitive than serum creatinine to detect early decrease in kidney function.

Original languageEnglish
Pages (from-to)1236-1239
Number of pages4
JournalPediatric Blood and Cancer
Volume50
Issue number6
DOIs
StatePublished - Jun 1 2008

Fingerprint

Albuminuria
Sickle Cell Anemia
Proteinuria
Creatinine
Serum
Cystatin C
Hydroxyurea
Angiotensins
Kidney
Chronic Renal Insufficiency
Disease Progression
Young Adult
Albumins

Keywords

  • Albuminuria
  • Hemoglobinopathy
  • Serum creatinine
  • Serum cystatin C
  • Sickle cell disease
  • Sickle nephropathy

ASJC Scopus subject areas

  • Cancer Research
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Short-term follow-up of patients with sickle cell disease and albuminuria. / Alvarez, Ofelia A; Lopez-Mitnik, Gabriela; Zilleruelo, Gaston E.

In: Pediatric Blood and Cancer, Vol. 50, No. 6, 01.06.2008, p. 1236-1239.

Research output: Contribution to journalArticle

Alvarez, Ofelia A ; Lopez-Mitnik, Gabriela ; Zilleruelo, Gaston E. / Short-term follow-up of patients with sickle cell disease and albuminuria. In: Pediatric Blood and Cancer. 2008 ; Vol. 50, No. 6. pp. 1236-1239.
@article{f1cbccb1a9f14d3ebeabaa4dd92925fe,
title = "Short-term follow-up of patients with sickle cell disease and albuminuria",
abstract = "Background. Albuminuria with normal serum creatinine occurs frequently in patients with sickle cell disease (SCD), but the rate of progression to more advanced chronic renal disease is unknown. The purpose of this study was to investigate the rate of progression of children and young adults with SCD and albuminuria over time. Procedure. Urine albumin/creatinine (A/C) ratios and serum creatinine were obtained serially. Serum cystatin C levels were determined in a subgroup of 20 patients. Results. Of 38 patients with SCD who had albuminuria (30 with microalbuminuria and 8 with proteinuria), 10.5{\%} had progressive disease during follow-up of 20 ± 12 months. Progressive disease was observed in 2 of 30 patients with MA because MA worsened to either intermittent proteinuria (1 patient), or persistent proteinuria after 7 months follow-up (1 patient). Two of eight patients with proteinuria worsened to nephrotic-range after 8 and 17 months with elevations of serum creatinine. All eight patients with proteinuria were treated with angiotensin blockade and/or hydroxyurea. Of those, six patients responded to treatment with decreased albuminuria and no changes in serum creatinine. Serum cystatin C level trended to increase before serum creatinine in patients with proteinuria. Conclusions. Patients with rapid progression to nephrotic-range proteinuria showed decreased kidney function. Therefore, patients with albuminuria should be monitored closely for progression, and therapy with hydroxyurea and/or angiotensin blockade should be considered for patients who develop proteinuria. Serum cystatin C appears more sensitive than serum creatinine to detect early decrease in kidney function.",
keywords = "Albuminuria, Hemoglobinopathy, Serum creatinine, Serum cystatin C, Sickle cell disease, Sickle nephropathy",
author = "Alvarez, {Ofelia A} and Gabriela Lopez-Mitnik and Zilleruelo, {Gaston E}",
year = "2008",
month = "6",
day = "1",
doi = "10.1002/pbc.21520",
language = "English",
volume = "50",
pages = "1236--1239",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Short-term follow-up of patients with sickle cell disease and albuminuria

AU - Alvarez, Ofelia A

AU - Lopez-Mitnik, Gabriela

AU - Zilleruelo, Gaston E

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Background. Albuminuria with normal serum creatinine occurs frequently in patients with sickle cell disease (SCD), but the rate of progression to more advanced chronic renal disease is unknown. The purpose of this study was to investigate the rate of progression of children and young adults with SCD and albuminuria over time. Procedure. Urine albumin/creatinine (A/C) ratios and serum creatinine were obtained serially. Serum cystatin C levels were determined in a subgroup of 20 patients. Results. Of 38 patients with SCD who had albuminuria (30 with microalbuminuria and 8 with proteinuria), 10.5% had progressive disease during follow-up of 20 ± 12 months. Progressive disease was observed in 2 of 30 patients with MA because MA worsened to either intermittent proteinuria (1 patient), or persistent proteinuria after 7 months follow-up (1 patient). Two of eight patients with proteinuria worsened to nephrotic-range after 8 and 17 months with elevations of serum creatinine. All eight patients with proteinuria were treated with angiotensin blockade and/or hydroxyurea. Of those, six patients responded to treatment with decreased albuminuria and no changes in serum creatinine. Serum cystatin C level trended to increase before serum creatinine in patients with proteinuria. Conclusions. Patients with rapid progression to nephrotic-range proteinuria showed decreased kidney function. Therefore, patients with albuminuria should be monitored closely for progression, and therapy with hydroxyurea and/or angiotensin blockade should be considered for patients who develop proteinuria. Serum cystatin C appears more sensitive than serum creatinine to detect early decrease in kidney function.

AB - Background. Albuminuria with normal serum creatinine occurs frequently in patients with sickle cell disease (SCD), but the rate of progression to more advanced chronic renal disease is unknown. The purpose of this study was to investigate the rate of progression of children and young adults with SCD and albuminuria over time. Procedure. Urine albumin/creatinine (A/C) ratios and serum creatinine were obtained serially. Serum cystatin C levels were determined in a subgroup of 20 patients. Results. Of 38 patients with SCD who had albuminuria (30 with microalbuminuria and 8 with proteinuria), 10.5% had progressive disease during follow-up of 20 ± 12 months. Progressive disease was observed in 2 of 30 patients with MA because MA worsened to either intermittent proteinuria (1 patient), or persistent proteinuria after 7 months follow-up (1 patient). Two of eight patients with proteinuria worsened to nephrotic-range after 8 and 17 months with elevations of serum creatinine. All eight patients with proteinuria were treated with angiotensin blockade and/or hydroxyurea. Of those, six patients responded to treatment with decreased albuminuria and no changes in serum creatinine. Serum cystatin C level trended to increase before serum creatinine in patients with proteinuria. Conclusions. Patients with rapid progression to nephrotic-range proteinuria showed decreased kidney function. Therefore, patients with albuminuria should be monitored closely for progression, and therapy with hydroxyurea and/or angiotensin blockade should be considered for patients who develop proteinuria. Serum cystatin C appears more sensitive than serum creatinine to detect early decrease in kidney function.

KW - Albuminuria

KW - Hemoglobinopathy

KW - Serum creatinine

KW - Serum cystatin C

KW - Sickle cell disease

KW - Sickle nephropathy

UR - http://www.scopus.com/inward/record.url?scp=42349111068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42349111068&partnerID=8YFLogxK

U2 - 10.1002/pbc.21520

DO - 10.1002/pbc.21520

M3 - Article

C2 - 18293385

AN - SCOPUS:42349111068

VL - 50

SP - 1236

EP - 1239

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 6

ER -